Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Maraicar, K. Shahul Hammed
- A Robust Clinical Information on King of Carotenoids: a Systematic Review of the Literature
Abstract Views :578 |
PDF Views:437
Authors
J. Balasubramanian
1,
N. Narayanan
2,
K. Shahul Hammed Maraicar
2,
M. Murugan
2,
K. Azhagesh Raj
2,
M. Aruna
2
Affiliations
1 Shield Health Care Pvt Ltd, Chennai-600095,Tamilnadu, IN
2 Periyar Maniammai UniversityThanjavur-613403,Tamilnadu, IN
1 Shield Health Care Pvt Ltd, Chennai-600095,Tamilnadu, IN
2 Periyar Maniammai UniversityThanjavur-613403,Tamilnadu, IN
Source
Indian Journal of Drugs and Diseases, Vol 1, No 1 (2012), Pagination: 18-25Abstract
Astaxanthin is a red carotenoid pigment extensively found in living organisms. Though Astaxanthin is a carotenoid compound, unlike β-carotene (a vitamin A precursor), cannot be converted to vitamin A. Astaxanthin, a potent antioxidant,with other biological effects protects cell membranes from harmful damage in the body. Studies suggest Astaxanthin may be effective in treating diseases, including cardiovascular, immune disorders, tumor, diabetes, neurodegenerative conditions and inflammatory conditions. Recent studies on Astaxanthin have shown enhancing immune response and decreasing DNA damage in humans. Astaxanthin is capable of crossing the blood-brain barrier in mammals.Keywords
Astaxanthin, Antioxidant, Immune ResponseReferences
- Aoi W, Naito Y, Takanami Y, Ishii T, Akagiri S, Kato Y, Osawa T and Yoshikawa T (2008). Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification. Biochem. Biophys. Res. Commun. 366(4),892-7. Epub 2007 Dec 17.
- Fassett RG, Coombes JS (2009) Astaxanthin, Oxidative stress, inflammation and cardiovascular disease. Future Cardiol. 5(4), 333-342.
- Ikeuchi M, Koyama T, Takahashi J and Yazawa K (2006) Effects of Astaxanthin supplementation on exercise-induced fatigue in mice. Biol. Pharm. Bull. 29(10), 2106-10.
- Ikeuchi M, Koyama T, Takahashi J and Yazawa K (2007) Effects of Astaxanthin in obese mice fed a high-fat diet. Biosci .Biochem. 71 (4), 893-9. Epub 2007 Apr 7.
- Iwasaki and Tawara (2006) Effects of Astaxanthin on eyestrain induced by accommodative dysfunction. J.Eye (Atarashi Ganka) (6),829-834.
- Jyonouchi H et al.(2000) Antitumor activity of Astaxanthin and its mode of action. Nutr. Cancer.36(1),59-65.
- Miki W (1991) Biological functions and activities of animal carotenoids. Pure Appl. Chem. 63:141.
- Miyawaki et al., (2005) Effects of Astaxanthin on human blood rheology. J.Clin. Therap. Med. 21(4),421-429.
- Nagaki et al.(2005) The effect of Astaxanthin on retinal capillary blood flow in normal volanteers. J.Clin. Opthal.28(5),537-542.
- Nagaki et al., (2006) The supplementation effect of Astaxanthin on accommodative and asthennopia. J. Clin.Therap.Me.22(1),41-54.
- Nagaki Y et al., (2002) Effects of Astaxanthin on accommodation, critical flicker fusions, and pattern evoked potential in visual disply terminal workers. J.Trad. Med. 19(5), 170-173.
- Naguib YM (2000) Antioxidant activities of Astaxanthin and related carotenoids. J. Agric. Food Chem. 48(4),1150-1154.
- Nakamura et al.(2004) Changes in visual function following peroral Astaxanthin. Japan J. Clin.Ophtal. 58(6),1051-1054.
- Nitta et al. (2005) Effects of Astaxanthin on accommodation and asthenopia –dose finding study in healthy volenteers.J.Clin.Therap. Med.21(6),637- 650.
- Ohgami et al.(2003) Effects of Astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest. Opthal. Vis. Sci.44 (6), 2694-2701.
- Sawaki K et al. (2002) Sports performance benefits from taking natural Astaxanthin characterized by visual activity and muscle fatigue improvements in humans. J. Clin. Ther. Med. 18(9), 73-88.
- Shiratori et al. (2005) Effect of Astaxanthin on accommodation and asthenopia- Efficancy identification study in healthy volunteers. J.Clin.Therap.Med. 21 (5), 543- 556.
- Suzuki et al., (2006) Suppressive effects of Astaxanthin against rat endotoxin –induced uveitis by inhibiting the NF-kB signalling pathway.Exp.Eye Res.82,275-281.
- Takahashi and Kajita(2005) Effects of Astaxanthin on accommodative recovery. J.Clin.Therap. Med. 21(4),431-436.
- Terao J (1989) Antioxidant activity of betacarotene and related carotenoids in solution. Lipids .24:659.
- Tso MO and Lam TT (1996) Method of retarding and ameliorating central nervous system and eye damage. US Patent 5,527,533.
- Yoshida H, Yanai H, Ito K, Tomono Y, Koikeda T, Tsukahara H and Tada N (2009). Administration of natural Astaxanthin increases serum HDL-cholesterol and (2):520-523. Epub 2009 Oct 14.
- DHEA: The Remedy for Andropause
Abstract Views :557 |
PDF Views:393
Authors
J. Balasubramanian
1,
K. Shahul Hammed Maraicar
1,
D. Babu Ananth
1,
N. Vijayakumar
1,
R. Dhanalakishmi
1
Affiliations
1 Shield Health Care Pvt Ltd, Chennai-600095, Tamilnadu, IN
1 Shield Health Care Pvt Ltd, Chennai-600095, Tamilnadu, IN
Source
Indian Journal of Medicine and Healthcare, Vol 1, No 2 (2012), Pagination: 29-31Abstract
Andropause is a clinical and biochemical syndrome associated with advancing age in males and mainly characterized by a deficiency in serum (blood) androgen, mostly testosterone, levels. The condition is sometimes referred to as Androgen Decline in the Aging Male (ADAM), Partial Androgen Deficiency in the Aging Male (PADAM) or Aging Associated Androgen Deficiency (AAAD). Although the term andropause is used most often in the scientific literature, it is actually something of a misnomer because androgen releases never fully stops or "pauses" in the majority of aging men. A growing body of research suggests that DHEA can prevent or reverse the diseases that anti-aging experts have identified as the most prominent markers of accelerated aging: atherosclerosis (hardening and clogging o f the arteries), cancer, diabetes, and reduced immunity.Keywords
Androgen Decline, Aging Associated Decline, Aging Associated Androgen DeficiencyReferences
- Alexandersen P, Haarbo J and Christiansen C (1996) The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis. 125(1), 1-13.
- Arlt W (2004) Dehydroepiandrosterone and aging, best practice & research. Clin. endocrinology & metabolism. 18 (3), 363–380.
- Arnlov J, Pencina MJ and Amin S et al. (2006) Endogenous sex hormones and cardiovascular disease incidence in men. Ann. Intern. Med. 145 (3), 176–184.
- Barrett-Connor E, Khaw KT and Yen SS (1986) A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N. Engl. J. Med. 315 (24), 1519–1524.
- Baulieu EE, Thomas G Legrain S et al. (2000) DHEA sulfate, and aging: contribution of the DHEA ge study to a sociobiomedical issue. Proc. Natl. Acad. Sci. USA. 97, 4279-4284.
- Christeff N, Lortholary O and Casassus P et al. (1996) Relationship between sex steroid hormone levels and CD4 lymphocytes in HIV infected men. Exp. Clin. Endocrinol. Diabetes. 104(2),130-136.
- Crosbie D, Black C, McIntyre L, Royle PL and Thomas S (2007) Dehydroepiandrosterone for systemic lupus erythematosus. Cochrane database of systematic rev. (4), CD005114.
- Cunningham SK and McKenna TJ (1994) Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome. Clin. Endocrinol. 41,795.
- Derksen RH (1998) Dehydroepiandrosterone and systemic lupus erythematosus. Semin. Arthritis Rheum. 27, 335-347.
- Fuller SJ, Tan RS and Martins RN (2007) Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions. J. Alzheimer's disease.12 (2), 129–142.
- Labrie F, Belanger A, et al. (1998) DHEA and the intracrine formatoin of androgens and estrogens in perioheral target tissues: its role during aging. Steroids. 63(5-6), 322-328.
- Longcope C (1996) Dehydroepiandrosterone metabolism. J. Endocrinol. 150(suppl), S125-S127.
- Morales AJ et al. (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endorcrionol. Metab. 78, 1360- 1367.
- Morales AJ, Haubrich RH, Hwang JY et al. (1998) The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin. Endocrinol. 49, 421-432.
- Orentreich N (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrin. Metabolism. 59,551-555.
- Rabkin JG, Ferrando SJ, Wagner GJ et al. (2000) DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology. 25(1), 53-68.
- Rabkin JG, McElhiney MC, Rabkin R, McGrath PJ and Ferrando SJ (2006) Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Am. J. Psychiatry. 163(1), 59-66.
- Roberts E (1999) The importance of dehydroepiandrosterone sulfate in the blood of primates: a longer and healthier life. Biochemical Pharmacol. 57 (4), 329-346.
- Schulman, Robert A, Dean MD and Carolyn, MD (2007) DHEA is a common hormone produced in the adrenal glands, the gonads, and the brain. pp:100.
- Schulz S, Klann RC, Schönfeld S and Nyce JW (1992) Mechanisms of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: role of isoprenoid biosynthesis. Cancer Res. 52 (5),1372–1376.
- Thijs L, Fagard R, Forette F, Nawrot T and Staessen JA (2003) Are low dehydro epiandrosterone sulfate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies. Acta. Cardiol. 58(5), 403-410.
- Tummala S and Svec F (1999) Correlation between the administered dose of DHEA and serum levels of DHEA and DHEA-S in human volunteers: analysis of published data. Clin. Biochem. 32, 355-361.
- Van Vollenhoven RF (2000) Dehydroepiandrosterone in systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 26,349- 362.
- Van Vollenhoven RF, Engleman EG and McGuire JL (1995) Dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum. 38, 1826-1831.
- VanVollenhover RF and McGuire JL (1994) An open study of DHEA in systemic lupus Erythematosis. Arthritis & Rheumatism. 37(9), 1305-1310. 26. Wyllie M (2003) ADAM and the andropause. Brit. J. Urol. Int.91, 883-884.
- William F and Ganong MD (2005) Review of medical physiology, 22nd Ed, McGraw Hill, 2005, page 362.
- Zumoff BV and Bradlow HL (1980) Sex difference in the metabolism of dehydroepiandrosterone sulfate. J. Clin. Endocrinol. Metab. 51, 334-346.